
Ingenii is a company specializing in quantum machine learning (QML) enablement for the life sciences sector. They provide training programs, quantum feasibility assessments, and custom quantum AI solutions focused on drug discovery, medical imaging, and clinical trials. Their business model includes premium QML courses and consulting services to help life sciences organizations integrate quantum computing into their machine learning pipelines. Ingenii differentiates itself by combining deep expertise in quantum algorithms with practical applications in biotech and pharma, supported by strategic partnerships and an expert advisory board. They are part of the Duality Accelerator, enhancing their market position in quantum technology for life sciences innovation.

Ingenii is a company specializing in quantum machine learning (QML) enablement for the life sciences sector. They provide training programs, quantum feasibility assessments, and custom quantum AI solutions focused on drug discovery, medical imaging, and clinical trials. Their business model includes premium QML courses and consulting services to help life sciences organizations integrate quantum computing into their machine learning pipelines. Ingenii differentiates itself by combining deep expertise in quantum algorithms with practical applications in biotech and pharma, supported by strategic partnerships and an expert advisory board. They are part of the Duality Accelerator, enhancing their market position in quantum technology for life sciences innovation.